AIP vs MGRT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AIP's Piotroski F-Score of 4/9 indicates weak financial health, with only a marginal stability rating. The absence of an Altman Z-Score raises concern about bankruptcy risk, especially given negative profitability metrics and a high forward P/E of 141.59. Despite strong revenue growth (30% YoY) and recent earnings beat consistency, the company operates at a significant loss with a -49.23% profit margin and negative ROA (-18.73%). Insider selling activity totaling $8.83M over six months signals bearish sentiment, and the stock trades at a steep price-to-sales of 9.42, suggesting overvaluation relative to fundamentals. The lack of dividend and weak technical trend further undermine investor confidence.
MGRT exhibits a stable financial foundation with a Piotroski F-Score of 5/9 and exceptional liquidity, but it is currently trading in a state of extreme speculative euphoria. The current price of $49.24 represents a massive premium over both the Graham Number ($2.08) and the Intrinsic Value ($5.02), with a P/E ratio of 289.65 that is unsustainable. Despite hyper-growth in revenue (308.8%) and earnings, the technical trend has turned sharply bearish (10/100), suggesting a peak has been reached. The disconnect between fundamental value and market price creates a high risk of a significant correction.
Compare Another Pair
Related Comparisons
AIP vs MGRT: Head-to-Head Comparison
This page compares Arteris, Inc. (AIP) and Mega Fortune Company Limited (MGRT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.